Marbodug 20 mg/ml solution for injection for cattle and pigs
Marbodug 20 mg/ml solution for injection for cattle and pigs
Authorised
- Marbofloxacin
Product identification
Medicine name:
Marbodug 20 mg/ml solution for injection for cattle and pigs
Odimar 20 mg/ml Oplossing voor injectie
Odimar 20 mg/ml Solution injectable
Odimar 20 mg/ml Injektionslösung
Active substance:
- Marbofloxacin
Target species:
-
Cattle
-
Pig
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Marbofloxacin20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal6dayPre-ruminating calves (up to 100kg bodyweight)
-
-
Pig
-
Meat and offal4day
-
-
-
Intravenous use
-
Cattle
-
Meat and offal6day
-
-
-
Subcutaneous use
-
Cattle
-
Meat and offal6day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA93
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Packaged in Amber type II glass vial of 10ml.Vial is closed with a fluorinated bromobutyl rubber stopper and oversealed with an aluminium cap.Each vial is packaged in a cardboard box.
- Packaged in Amber type II glass vial of 20ml.Vial is closed with a fluorinated bromobutyl rubber stopper and oversealed with an aluminium cap.Each vial is packaged in a cardboard box.
- Packaged in Amber type II glass vial of 50ml.Vial is closed with a fluorinated bromobutyl rubber stopper and oversealed with an aluminium cap.Each vial is packaged in a cardboard box.
- Packaged in Amber type II glass vial of 100ml.Vial is closed with a fluorinated bromobutyl rubber stopper and oversealed with an aluminium cap.Each vial is packaged in a cardboard box.
- Packaged in Amber type II glass vial of 250ml.Vial is closed with a fluorinated bromobutyl rubber stopper and oversealed with an aluminium cap.Each vial is packaged in a cardboard box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V434761
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0457/001
Concerned member states:
-
Austria
-
Belgium
-
Germany
-
Luxembourg
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 15/12/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
